BIOIATRIKI Healthcare Group’s Cytogenetics and Molecular Cytogenetics departments are the exemplar of modern departments in the field of chromosomal abnormalities diagnosis.
They contribute significantly to the prenatal and postnatal diagnosis of chromosomal abnormalities, and to the genetic defects in hematologic neoplasms.
Our goal is the reliable and fast provision of accredited diagnostic genetic tests to physicians, obstetricians-gynecologists, hematologists, endocrinologists, oncologists, pediatricians, and doctors of other specialties. We apply all modern techniques of Cytogenetics and Molecular Cytogenetics which relate to congenital and acquired chromosomal abnormalities.
In the laboratory, we perform all the tests needed for the analysis of numerical and structural chromosomal lesions (fragile sites) via conventional and molecular karyotyping, as well as via the fluorescence in situ hybridization (FISH) method.
More specifically, we screen for:
BIOIATRIKI Healthcare Group’s Cytogenetics and Molecular Cytogenetics departments are the exemplar of modern departments in the field of chromosomal abnormalities diagnosis.
They contribute significantly to the prenatal and postnatal diagnosis of chromosomal abnormalities, and to the genetic defects in hematologic neoplasms.
Our goal is the reliable and fast provision of accredited diagnostic genetic tests to physicians, obstetricians-gynecologists, hematologists, endocrinologists, oncologists, pediatricians, and doctors of other specialties. We apply all modern techniques of Cytogenetics and Molecular Cytogenetics which relate to congenital and acquired chromosomal abnormalities.
In the laboratory, we perform all the tests needed for the analysis of numerical and structural chromosomal lesions (fragile sites) via conventional and molecular karyotyping, as well as via the fluorescence in situ hybridization (FISH) method.
More specifically, we screen for:
